Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
9.4 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Pharmacy benefits managers; licensure and regulation definitions. | Pharmacy benefits managers; licensure and regulation. Provides that no person is authorized to provide pharmacy benefits management services or otherwise act as a pharmacy benefits manager without first obtaining a license from the State Corporation Commission. The measure prohibits a carrier on its own or through its contracted pharmacy benefits manager or representative of a pharmacy benefits manager from (i) causing or knowingly permitting the use of any advertisement, promotion, solicitation, representation, proposal, or offer that is untrue; (ii) charging a pharmacist or pharmacy a fee related to the adjudication of a claim other than a reasonable fee for an initial claim submission; (iii) reimbursing a pharmacy or pharmacist an amount less than the amount that the pharmacy benefits manager reimburses a pharmacy benefits manager affiliate for providing the same pharmacist services, calculated on a per-unit basis using the same generic product identifier or generic code number and reflecting all drug manufacturer's rebates, direct and indirect administrative fees, and costs and any remuneration; or (iv) penalizing or retaliating against a pharmacist or pharmacy for exercising rights provided by this measure. The measure also prohibits a carrier from (a) imposing provider accreditation standards or certification requirements inconsistent with, more stringent than, or in addition to requirements of the Virginia Board of Pharmacy or other state or federal entity; (b) including any mail order pharmacy or pharmacy benefits manager affiliate in calculating or determining network adequacy; or (c) conducting spread pricing in the Commonwealth. The measure also imposes recordkeeping and reporting requirements. The bill has a delayed effective date of October 1, 2020. This bill incorporates SB 252 and SB 862 and is identical to HB 1290. | us/states/va | Virginia General Assembly | 2020 | SB 251 | Virginia SB 251 (2020) |
|
enacted |
|
4 | 46 | 10 | 2020-01-02 | 2020-05-21 | openstates | ocd-bill/b1a16df4-740c-428a-9399-bbbbdfb9c7a8 | https://lis.virginia.gov/cgi-bin/legp604.exe?201+sum+SB251 | 4422e81e70722e03b58a29d3b15e2b27874e90165cea86981ff3bc0d96ccc8a9 | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Virginia SB 251 (2020) — Pharmacy benefits managers; licensure and regulation definitions.
Pharmacy benefits managers; licensure and regulation. Provides that no person is authorized to provide pharmacy benefits management services or otherwise act as a pharmacy benefits manager without first obtaining a license from the State Corporation Commission. The measure prohibits a carrier on its own or through its contracted pharmacy benefits manager or representative of a pharmacy benefits manager from (i) causing or knowingly permitting the use of any advertisement, promotion, solicitation, representation, proposal, or offer that is untrue; (ii) charging a pharmacist or pharmacy a fee related to the adjudication of a claim other than a reasonable fee for an initial claim submission; (iii) reimbursing a pharmacy or pharmacist an amount less than the amount that the pharmacy benefits manager reimburses a pharmacy benefits manager affiliate for providing the same pharmacist services, calculated on a per-unit basis using the same generic product identifier or generic code number and reflecting all drug manufacturer's rebates, direct and indirect administrative fees, and costs and any remuneration; or (iv) penalizing or retaliating against a pharmacist or pharmacy for exercising rights provided by this measure. The measure also prohibits a carrier from (a) imposing provider accreditation standards or certification requirements inconsistent with, more stringent than, or in addition to requirements of the Virginia Board of Pharmacy or other state or federal entity; (b) including any mail order pharmacy or pharmacy benefits manager affiliate in calculating or determining network adequacy; or (c) conducting spread pricing in the Commonwealth. The measure also imposes recordkeeping and reporting requirements. The bill has a delayed effective date of October 1, 2020. This bill incorporates SB 252 and SB 862 and is identical to HB 1290.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- Acts of Assembly Chapter text (CHAP1288) (committee substitute) — source
- Bill text as passed Senate and House (SB251ER) (committee substitute) — source
- Engrossed by Senate - committee substitute SB251S1 (committee substitute) — source
- Impact statement from SCC (SB251) (committee substitute) — source
Votes
- Reconsideration of Governor's recommendation agreed to (40-Y 0-N) — 40–0 (pass) · upper
- Senate rejected Governor's recommendation (19-Y 21-N) — 19–21 (fail) · upper
- VOTE: Block Vote Passage (98-Y 0-N) — 97–0 (pass) · lower
- Reconsideration of Governor's recommendation rejected (35-Y 3-N) — 35–3 (pass) · upper
- Constitutional reading dispensed (40-Y 0-N) — 40–0 (pass) · upper
- Reported from Commerce and Labor with substitute (9-Y 6-N) — 9–6 (pass) · upper
- Senate rejected Governor's recommendation (19-Y 21-N) — 19–21 (fail) · upper
- Reported from Labor and Commerce with amendments (20-Y 0-N) — 20–0 (pass) · lower
- Read third time and passed Senate (33-Y 7-N) — 33–7 (pass) · upper
- House amendments agreed to by Senate (38-Y 2-N) — 38–2 (pass) · upper
Sponsors
- John S. Edwards — primary (person)
- A. Benton "Ben" Chafin — cosponsor (person)
- Siobhan S. Dunnavant — cosponsor (person)
- Todd E. Pillion — cosponsor (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2020-01-02 Prefiled and ordered printed; offered 01/08/20 20101086D
introduction - 2020-01-02 Referred to Committee on Commerce and Labor
referral-committee - 2020-01-15 Assigned C&L sub: Health Insurance
referral-committee - 2020-01-16 Impact statement from SCC (SB251)
- 2020-01-27 Reported from Commerce and Labor with substitute (9-Y 6-N)
committee-passage - 2020-01-27 Incorporates SB252 (Edwards)
- 2020-01-27 Incorporates SB862 (Pillion)
- 2020-01-27 Committee substitute printed 20105876D-S1
substitution - 2020-01-29 Constitutional reading dispensed (40-Y 0-N)
- 2020-01-30 Passed by for the day
- 2020-01-31 Passed by for the day
- 2020-02-03 Read second time
reading-2 - 2020-02-03 Reading of substitute waived
- 2020-02-03 Committee substitute agreed to 20105876D-S1
- 2020-02-03 Reading of amendments waived
- 2020-02-03 Amendments by Senator Hanger rejected
amendment-failure - 2020-02-03 Engrossed by Senate - committee substitute SB251S1
- 2020-02-04 Read third time and passed Senate (33-Y 7-N)
passage, reading-3 - 2020-02-04 Impact statement from SCC (SB251S1)
- 2020-02-18 Placed on Calendar
- 2020-02-18 Read first time
reading-1 - 2020-02-18 Referred to Committee on Labor and Commerce
referral-committee - 2020-02-18 Reported from Labor and Commerce with amendments (20-Y 0-N)
committee-passage - 2020-02-20 Read second time
reading-2 - 2020-02-21 Read third time
reading-3 - 2020-02-21 Committee amendments agreed to
- 2020-02-21 Engrossed by House as amended
- 2020-02-21 Passed House with amendments BLOCK VOTE (98-Y 0-N)
passage - 2020-02-21 VOTE: Block Vote Passage (98-Y 0-N)
- 2020-02-25 House amendments agreed to by Senate (38-Y 2-N)
- 2020-03-02 Enrolled
- 2020-03-02 Impact statement from SCC (SB251ER)
- 2020-03-02 Signed by Speaker
- 2020-03-03 Signed by President
- 2020-03-12 Enrolled Bill Communicated to Governor on March 12, 2020
- 2020-03-12 Governor's Action Deadline 11:59 p.m., April 11, 2020
- 2020-04-11 Governor's recommendation received by Senate
- 2020-04-22 Senate rejected Governor's recommendation (19-Y 21-N)
- 2020-04-22 Reconsideration of Governor's recommendation agreed to (40-Y 0-N)
- 2020-04-22 Passed by temporarily
- 2020-04-22 Senate rejected Governor's recommendation (19-Y 21-N)
- 2020-04-22 Reconsideration of Governor's recommendation rejected (35-Y 3-N)
- 2020-04-22 Second reconsideration requires unanimous consent
- 2020-04-22 Communicated to Governor
- 2020-04-22 Governor's Action Deadline 11:59 p.m., May 22, 2020
- 2020-05-21 Approved by Governor-Chapter 1288 (effective - see bill)
executive-signature
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/b1a16df4-740c-428a-9399-bbbbdfb9c7a8. Confidence: reported (aggregated from official Virginia legislature records).